These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8137217)

  • 1. Hormonal ablation as effective therapy for carcinomatous meningitis from prostatic carcinoma.
    Mencel PJ; DeAngelis LM; Motzer RJ
    Cancer; 1994 Apr; 73(7):1892-4. PubMed ID: 8137217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinoma.
    Figg WD; Kroog G; Duray P; Walther MM; Patronas N; Sartor O; Reed E
    Cancer; 1997 May; 79(10):1964-8. PubMed ID: 9149024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of intermittent androgen ablation in advanced prostate cancer in Japanese men.
    Egawa S; Takashima R; Matsumoto K; Mizoguchi H; Kuwao S; Baba S
    Jpn J Clin Oncol; 2000 Jan; 30(1):21-6. PubMed ID: 10770564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma.
    Ferreira Filho AF; Cardoso F; Di Leo A; Awada A; da Silva VD; Tovar RB; Schwartsmann G
    Ann Oncol; 2001 Dec; 12(12):1757-9. PubMed ID: 11843255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of localized prostate cancer with intermittent triple androgen blockade: preliminary results in 110 consecutive patients.
    Leibowitz RL; Tucker SJ
    Oncologist; 2001; 6(2):177-82. PubMed ID: 11306729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination effect of flutamide and leuprorelin acetate on growth of Dunning R3327-H prostatic adenocarcinoma in rats].
    Tomura A; Kuroiwa S; Okada M; Abe F
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):563-9. PubMed ID: 9530363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment versus LHRH alone in advanced prostatic cancer.
    Ferrari P; Castagnetti G; Ferrari G; Baisi B; Dotti A
    Urol Int; 1996; 56 Suppl 1():13-7. PubMed ID: 8776812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mediastinal lymph nodes during the course of a metastatic prostate cancer].
    Roca Edreira A; Aguilera Tubet C; Villanueva Peña A; Ballestero Diego R; Zubillaga Guerrero S
    Actas Urol Esp; 2007 Jun; 31(6):693-5; discussion 695. PubMed ID: 17896567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure in a patient receiving treatment with suramin.
    Smith A; Harbour D; Liebmann J
    Am J Clin Oncol; 1997 Aug; 20(4):433-4. PubMed ID: 9256906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary treatment for stage D2 prostate cancer: a randomized study of combined androgen blockade alone versus combined with UFT].
    Sumiyoshi Y; Hashine K; Kuwahara M; Aki M; Yamamoto A; Akazawa S; Takenaka A
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1153-8. PubMed ID: 10431581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
    Diamond T; Campbell J; Bryant C; Lynch W
    Cancer; 1998 Oct; 83(8):1561-6. PubMed ID: 9781950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant pleural effusion from prostatic adenocarcinoma resolved with hormonal therapy.
    Carrascosa M; Perez-Castrillon JL; Mendez MA; Cillero L; Valle R
    Chest; 1994 May; 105(5):1577-8. PubMed ID: 8181358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic prostatic adenocarcinoma presenting as a pituitary mass: shrinkage of the lesion and clinical improvement with medical treatment.
    Losa M; Grasso M; Giugni E; Mortini P; Acerno S; Giovanelli M
    Prostate; 1997 Sep; 32(4):241-5. PubMed ID: 9288182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal spontaneous tumor lysis syndrome in a patient with metastatic, androgen-independent prostate cancer.
    Lin CJ; Hsieh RK; Lim KH; Chen HH; Cheng YC; Wu CJ
    South Med J; 2007 Sep; 100(9):916-7. PubMed ID: 17902299
    [No Abstract]   [Full Text] [Related]  

  • 15. Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma.
    Sciarra A; Monti S; Gentile V; Mariotti G; Cardi A; Voria G; Lucera R; Di Silverio F
    Prostate; 2003 May; 55(3):168-79. PubMed ID: 12692782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).
    Small EJ; Halabi S; Dawson NA; Stadler WM; Rini BI; Picus J; Gable P; Torti FM; Kaplan E; Vogelzang NJ
    J Clin Oncol; 2004 Mar; 22(6):1025-33. PubMed ID: 15020604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.
    Dawson NA; Figg WD; Cooper MR; Sartor O; Bergan RC; Senderowicz AM; Steinberg SM; Tompkins A; Weinberger B; Sausville EA; Reed E; Myers CE
    J Clin Oncol; 1997 Apr; 15(4):1470-7. PubMed ID: 9193342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant hormonotherapy in patients with clinically-localized prostate cancer treated by radical prostatectomy: pathological results.
    Têtu B
    Can J Oncol; 1994 Nov; 4 Suppl 1():33-4; discussion 35-6. PubMed ID: 8853487
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
    Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
    Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful complete androgen blockade (CAB) therapy for prostatic cancer detected from multiple lung metastases: a case report].
    Tokumitsu M; Inada F; Kitahara K; Kawakami N; Masui N; Ishida H; Ishida H; Saga Y; Hashimoto H; Yachiku S
    Hinyokika Kiyo; 2001 Jan; 47(1):59-62. PubMed ID: 11235226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.